ProCE Banner Activity

Strategies for Initiating and Managing GLP-1 RAs in Cardiology Practice

Clinical Thought

Cardiovascular risk reduction is a key component of cardiology care, and it is imperative that healthcare professionals have strategies to integrate agents such as GLP-1 RAs into clinical practice. Here are some strategies to identify and mitigate barriers to GLP-1 RA initiation in cardiology practice.

Released: October 30, 2023

Expiration: October 30, 2024

Share

Faculty

Anne Peters

Anne Peters, MD

Director
USC Clinical Diabetes Programs
Professor of Clinical Medicine
Keck School of Medicine of USC
University of Southern California
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by an educational grant from Novo Nordisk.

Novo Nordisk

Disclosure

Primary Author

Anne Peters, MD

Director
USC Clinical Diabetes Programs
Professor of Clinical Medicine
Keck School of Medicine of USC
University of Southern California
Los Angeles, California

Anne Peters, MD: consultant/advisor/speaker: Abbott Diabetes Care, Lilly, Vertex, Zealand; researcher: Abbott Diabetes Care, Insulet; stock/stock options: Omada Health, Teladoc.